|
| operating_income = | net_income = | assets = | equity = | num_employees = 22,036 | parent = | subsid = | homepage = (www.cipla.com ) | Parent websites = (www.ciplausa.com ) | footnotes = }} Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India,〔(Cipla to buy 51% in Yemen distribution company | Business Line )〕〔(Cipla invests $1.5 million in Chase Pharma | Business Line )〕〔(Cipla gets 345 million rand South African contract | Business Line )〕 Belgium, Surrey in the European Union and Miami, Florida, in the United States; with manufacturing facilities in Goa (eight), Bengaluru (one), Baddi (one), Indore (one), Kurkumbh (one), Patalganga (one), and Sikkim (one), along with field stations in Delhi, Pune, and Hyderabad.〔(Cambridge varsity honour for Cipla chief | Business Line )〕 Cipla primarily develops medicines to treat cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.〔http://www.thehindubusinessline.com/companies/cipla-inks-coomercial-pact-with-bioquiddity-inc-for-anaesthetic-product/article6267251.ececonditions〕〔http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?symbol=CIPL.BO ''BusinessWeek''〕〔(How a little blue pill changed Cipla’s fortunes | Business Line )〕 As of 17 September 2014, its market capitalisation was , making it India's 42nd largest publicly traded company by market value.〔(Cipla to sell MSD’s HIV drug in India | Business Line )〕〔(Cipla, Hetero to roll out biosimilar drug | Business Line )〕 ==History== It was founded by Dr. Khwaja Abdul Hamied as 'The Chemical, Industrial & Pharmaceutical Laboratories' in 1935 in Mumbai.〔(【引用サイトリンク】title=About us - History )〕〔(【引用サイトリンク】title=Company History - Cipla Ltd. )〕 The name of the Company was changed to 'Cipla Limited' on 20 July 1984.〔 In the year 1985, US FDA approved the company's bulk drug manufacturing facilities.〔 In 1994, Cipla launched Deferiprone, the world’s first oral iron chelator.〔 In 2001, Cipla offered medicines (antiretrovirals) for HIV treatment at a fractional cost (less than $350 per year per patient). In 2012, the company slashed prices of three life-saving cancer drugs by 50-64%. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Cipla」の詳細全文を読む スポンサード リンク
|